Bimekizumab 3-year Efficacy in High-Impact Areas in Moderate to Severe Plaque Psoriasis: Pooled Results from Five Phase 3/3b Trials. J of Skin [Internet]. 2024 Jan. 16 [cited 2025 Jun. 25];8(1):s304. Available from: https://skin.dermsquared.com/skin/article/view/2446